tiprankstipranks

Fidia S.p.A. Adjusts Financial Calendar and Strengthens Management Team

Story Highlights
  • Fidia S.p.A. reschedules financial meetings to accommodate consolidated statement preparation.
  • Dr. Luca Carante appointed as Group Controller to bolster Fidia’s finance team.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Fidia S.p.A. Adjusts Financial Calendar and Strengthens Management Team

Fidia Spa ( (IT:FDA) ) just unveiled an update.

Fidia S.p.A. announced a change in its corporate events calendar, moving the meeting for the approval of the 2024 financial statements to April 16, 2025, and the Shareholders’ Meeting to May 19, 2025, due to the need to prepare a consolidated financial statement. Additionally, Dr. Luca Carante has been appointed as Group Controller, effective April 1, 2025, to enhance the company’s organizational structure in the Administration and Finance area.

More about Fidia Spa

Fidia S.p.A., based in San Mauro Torinese, is a leading company in the design, production, and marketing of high-performance integrated milling systems, primarily serving the automotive and aerospace sectors. With over 50 years of experience and around 160 employees, Fidia is recognized for its comprehensive solutions in the milling process, including numerical controls, high-speed milling systems, and CAM software for complex shapes.

Technical Sentiment Signal: Strong Sell

Current Market Cap: €220.7K

For an in-depth examination of FDA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App